Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study

BACKGROUND: Combination therapy with oxaliplatin, irinotecan, fluorouracil, and leucovorin (FOLFIRINOX) chemotherapy drastically improves survival of advanced pancreatic cancer patients. However, the efficacy of FOLFIRINOX as a second-line treatment after gemcitabine failure has not been tested pros...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jung Hoon, Lee, Sang-Cheol, Oh, Sung Yong, Song, Seo-Young, Lee, Namsu, Nam, Eun Mi, Lee, Soonil, Hwang, In Gyu, Lee, Hyo Rak, Lee, Kyu Taek, Bae, Sang-Byung, Kim, Han Jo, Jang, Joung Soon, Lim, Do Hyoung, Lee, Hyun Woo, Kang, Seok Yun, Kang, Jung Hun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993129/
https://www.ncbi.nlm.nih.gov/pubmed/29866170
http://dx.doi.org/10.1186/s40880-018-0304-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993129/
https://www.ncbi.nlm.nih.gov/pubmed/29866170
http://dx.doi.org/10.1186/s40880-018-0304-1

Ejemplares similares